Related Products of 106429-59-8, As we all know, there are many different methods for the synthesis of a compound, and people can choose the synthesis method that suits their own laboratory according to the actual situation. 106429-59-8 name is 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde, This compound is widely used in many fields, so it is necessary to find a new synthetic route. The downstream synthesis method of this compound is introduced below.
Step 4.5-((7-(5-((5-fluoro-2′-(1-hydroxyethyl)-[1,1′-biphenyl]-2-yl)oxy)pyrimidin-4-yl)- 2,7-diazaspiro[4.4]nonan-2-yl)methyl)-1H-benzo[d]imidazol-2(3H)-one (1074) To a solution of 1-(2′-((4-(2,7-diazaspiro[4.4]nonan-2-yl)pyrimidin-5-yl)oxy)-5′- fluoro-[1,1′-biphenyl]-2-yl)ethanol (330 mg, 0.66 mmol, crude) and 2-oxo-2,3-dihydro- 1H-benzo[d]imidazole-5-carbaldehyde (Intermediate 40, 106 mg, 0.66 mmol,) in MeOH (10 mL, anhydrous) was added AcOH (0.2 mL). The mixture was stirred at 17-25 C for about 30 min, then NaBH3CN (82 mg, 1.32 mmol) was added and the resulting mixture was stirred at 17-25 C for about 16 h. The mixture was quenched by sat. aq. NaHCO3 (10 mL) and extracted with CH2Cl2 (3 ¡Á 20 mL). The combined organic layers were washed with brine (20 mL), dried over Na2SO4, filtered and concentrated to give a residuewhich was purified by RP-HPLC method A to give 5-((7-(5-((5-fluoro-2′-(1- hydroxyethyl)-[1,1′-biphenyl]-2-yl)oxy)pyrimidin-4-yl)-2,7-diazaspiro[4.4]nonan-2- yl)methyl)-1H-benzo[d]imidazol-2(3H)-one (TFA salt) as a white solid. Yield: 290 mg. LCMS method C: Rt = 0.593 min, (M+H)+ = 581.21H NMR (CD3OD): delta 8.00-8.15 (m, 1 H), 7.50-7.70 (m, 2 H), 6.90-7.40 (m, 9 H), 4.67 (s, 1 H), 4.43 (s, 2 H), 3.35-3.95 (m, 8 H), 1.90-2.25 (m, 4 H), 1.20-1.35 (m, 3 H).19F NMR (CD3OD): delta -76.92, -117.29 ~ – 118.17.
At the same time, in my other blogs, there are other synthetic methods of this type of compound, 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde, and friends who are interested can also refer to it.
Reference:
Patent; VITAE PHARMACEUTICALS, INC.; CACATIAN, Salvacion; CLAREMON, David, A.; DILLARD, Lawrence, Wayne; DONG, Chengguo; FAN, Yi; JIA, Lanqi; LOTESTA, Stephen, D.; MARCUS, Andrew; MORALES-RAMOS, Angel; SINGH, Suresh, B.; VENKATRAMAN, Shankar; YUAN, Jing; ZHENG, Yajun; ZHUANG, Linghang; PARENT, Stephan, D.; HOUSTON, Travis, L.; (444 pag.)WO2017/214367; (2017); A1;,
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem